TURKISH JOURNAL OF OBSTETRICS AND GYNECOLOGY, cilt.19, sa.3, ss.246-256, 2022 (ESCI)
Objective: The current study assesss programmed death-1 (PD-1) receptor expression and CD3, CD4, and CD8 tumor-infiltrating lymphocytes (TILs) in high-grade serous ovarian cancer (HGSOC) and to associate our results with neoadjuvant chemotherapy history and disease prognosis.